NERPHARMA PART OF NMS GROUP
Live / Registered — Registered (as of 21 Feb 2023)
What this means for you
Registered since 21 Feb 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79326492
- Registration number
- 6982503
- Mark type
- Slogan / phrase
- Filed
- 09 Jul 2021
- Published for opposition
- 06 Dec 2022
- Registered
- 21 Feb 2023
- Attorney of record
- Jeffrey B. Sladkus, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations for treating cancer, myocardium infarction and malaria; sanitary preparations for medical purposes; biological preparations for medical purposes, namely, for the treatment of cancer, myocardium infarction and malaria; chemical preparations for pharmaceutical purposes, namely, for treating cancer, myocardium infarction and malaria; chemico-pharmaceutical preparations for treating disease, namely, treating cancer, myocardium infarction and malaria; diagnostic preparations for medical purposes; pharmaceutical preparations for treating cancer, myocardium infarction and malaria
- Class 041 — Education and entertainment services: Education, namely, providing classes, courses, seminars, workshops, related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; providing of training related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; providing entertainment in the nature of exhibitions, live shows, video and films, related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; know-how transfer training related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; providing online electronic publications, not downloadable, related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; publication of texts, other than publicity texts, related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; arranging and conducting of conferences, congresses and symposium in the medical and pharmaceutical fields
- Class 042 — Scientific and technological services: Scientific, technological, analysis and research services, namely, research and development in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; biological research in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; chemical research in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; clinical trials in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; quality control in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; scientific laboratory services
Owner
- NERPHARMA S.R.L., IT
- NERPHARMA S.R.L., IT
- NERPHARMA S.R.L., IT
Prosecution history
- 15 Nov 2024 — NEW REPRESENTATIVE AT IB RECEIVED
- 13 Jun 2023 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 24 May 2023 — FINAL DISPOSITION NOTICE SENT TO IB
- 24 May 2023 — FINAL DISPOSITION PROCESSED
- 21 May 2023 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 21 Feb 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 21 Feb 2023 — REGISTERED-PRINCIPAL REGISTER
- 12 Dec 2022 — NOTIFICATION PROCESSED BY IB
- 06 Dec 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Dec 2022 — PUBLISHED FOR OPPOSITION
- 23 Nov 2022 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 23 Nov 2022 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 16 Nov 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 30 Oct 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Sept 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED